Results 281 to 290 of about 20,261,505 (305)

Hepatitis C Virus

Annals of Internal Medicine, 2016
A. Kim
semanticscholar   +1 more source

The oncologic burden of hepatitis C virus infection: A clinical perspective

Ca-A Cancer Journal for Clinicians, 2017
Harrys A Torres, Filippo Miglior, Terri Lynn Shigle   +2 more
exaly  

Natural history of liver fibrosis progression in patients with chronic hepatitis C

The Lancet, 1997
T. Poynard, P. Bedossa, P. Opolon, Metavir Clinivir and Dosvirc groups for the OBSVIRC   +3 more
semanticscholar   +1 more source

The importance of immunization in cancer prevention, treatment, and survivorship

Ca-A Cancer Journal for Clinicians, 2017
Ted Gansler, Christopher R Flowers, Saad B Omer   +2 more
exaly  

Disparities in liver cancer occurrence in the United States by race/ethnicity and state

Ca-A Cancer Journal for Clinicians, 2017
Farhad Islami, Rebecca L Siegel, Ahmedin Jemal   +2 more
exaly  

Cancer‐related risk factors and preventive measures in US Hispanics/Latinos

Ca-A Cancer Journal for Clinicians, 2012
Priti Bandi
exaly  

Therapeutic strategies for hepatitis B virus infection: towards a cure

Nature Reviews Drug Discovery, 2019
Antonio Bertoletti, Fabien Zoulim, Jinlin Hou   +2 more
exaly  

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

Nature, 2005
E. Meylan, J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager, J. Tschopp   +6 more
semanticscholar   +1 more source

Hepatitis C therapeutics: current status and emerging strategies

Nature Reviews Drug Discovery, 2002
Ding-wei Ye
exaly  

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

Nature, 2009
Alexander Ploss, Matthew J Evans
exaly